Related Experiment Video
Updated: Oct 4, 2025
A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
Published on: December 9, 2015
Role of vitamin D deficiency and comorbidities in COVID-19
Gabriela Gama Freire Alberca1, Ricardo Wesley Alberca2
1Department of Microbiology, Institute of Biomedical Sciences-University of São Paulo, São Paulo 04307-100, Brazil.
Insights
Vitamin D deficiency is common in patients with COVID-19 and comorbidities. This review examines the links between these factors and COVID-19 outcomes, highlighting potential implications for patient care.
Area of Science:
- Endocrinology
- Infectious Diseases
- Public Health
Background:
- Vitamin D deficiency (hypovitaminosis D) is prevalent globally.
- Coronavirus disease 2019 (COVID-19) disproportionately affects individuals with comorbidities.
- Emerging evidence suggests a link between vitamin D status and COVID-19 severity.
Purpose of the Study:
- To review existing literature on the association between comorbidities, vitamin D deficiency, and COVID-19.
- To explore the potential role of vitamin D in modulating COVID-19 outcomes in patients with underlying health conditions.
Main Methods:
- Literature review of studies investigating vitamin D levels, comorbidities, and COVID-19.
- Synthesis of findings from observational studies and clinical reports.
- Analysis of the interplay between vitamin D status, common comorbidities, and COVID-19 prognosis.
Main Results:
- Multiple studies report lower vitamin D levels in COVID-19 patients compared to healthy controls.
- Comorbidities such as obesity, diabetes, and cardiovascular disease are frequently observed in COVID-19 patients with vitamin D deficiency.
- Vitamin D deficiency is associated with increased risk of severe COVID-19 and mortality.
Conclusions:
- Vitamin D deficiency is a significant concern in the context of COVID-19, particularly among individuals with comorbidities.
- Addressing vitamin D status may be a potential strategy to mitigate COVID-19 severity in at-risk populations.
- Further research is warranted to establish causality and optimal therapeutic strategies.
Abstract:
Recent manuscripts described the incidence of vitamin D hypovitaminosis in coronavirus disease 2019 (COVID-19) patients. Vitamin D deficiency is also common in patients with comorbidities that are associated with a poor COVID-19 prognosis. In this letter, we review the literature regarding the association of comorbidities, vitamin D deficiency, and COVID-19.
Related Concept Videos
01:25Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
01:23Role of Skin in Vitamin D Synthesis
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin...
01:30Vitamins
01:20COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
01:22Connective Tissue Cell Types
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...
01:29Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...